UC Berkeley researchers trained AI to detect hidden warning signs of sudden cardiac death in routine ECG tests, according to ...
The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.
Morning Overview on MSN
The Alzheimer’s drug memantine was tied to a higher risk of irregular heartbeat
Older adults taking memantine for Alzheimer’s disease may face a higher risk of irregular heartbeats, according to a growing body of evidence drawn from electronic health records and adverse-event ...
Background Preparticipation cardiovascular evaluation (PPE) is widely recommended to reduce the risk of sudden cardiac events ...
Please provide your email address to receive an email when new articles are posted on . A novel leadless conduction system pacemaker conferred stable pacing parameters at 1 month. The device dislodged ...
Please provide your email address to receive an email when new articles are posted on . A bipolar conduction system pacing implantable cardioverter defibrillator lead met safety and effectiveness ...
Some of the technologies that made headlines at HRS 2026. [Images courtesy of J&J, iRhythm, Abbott and Medtronic] Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
At the April 2026 Heart Rhythm Society Annual Meeting in Chicago, panelists gathered to discuss a myriad of topics in the rapidly growing cardiovascular care space. Song Zuo, MD, a specialist at the ...
Alivecor Inc. has secured CE marking for its Kardia 12L electrocardiogram (ECG) system, which is powered by its KAI 12L AI technology and can detect life-threatening cardiac conditions. Kardia 12L is ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...
Medtronic got an FDA approval for its OmniaSecure defibrillation lead, opening up its use in the heart’s left bundle branch, while Biotronik touted the commercial rollout of its Solia CSP S lead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results